These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3358995)

  • 21. Interval estimation of inverse dose-response.
    Alho JM; Valtonen E
    Biometrics; 1995 Jun; 51(2):491-501. PubMed ID: 7662838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to the letter of Hanley et al. ([1999] Teratology 59:323-324), concerning the article by Roy et al. ([1998] Teratology 58:62-68).
    Slotkin TA; Andrews JE
    Teratology; 1999 Oct; 60(4):177-8. PubMed ID: 10508970
    [No Abstract]   [Full Text] [Related]  

  • 23. Finite mixture models for proportions.
    Brooks SP; Morgan BJ; Ridout MS; Pack SE
    Biometrics; 1997 Sep; 53(3):1097-115. PubMed ID: 9333342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collaborative Behavioral Teratology Study: implications, current applications and future directions.
    Kimmel CA; Buelke-Sam J; Adams J
    Neurobehav Toxicol Teratol; 1985; 7(6):669-73. PubMed ID: 3835466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of toxicological endpoints by structure-activity relationships.
    Enslein K
    Pharmacol Rev; 1984 Jun; 36(2 Suppl):131S-135S. PubMed ID: 6382350
    [No Abstract]   [Full Text] [Related]  

  • 26. Joint models for toxicology studies with dose-dependent number of implantations.
    Allen AS; Barnhart HX
    Risk Anal; 2002 Dec; 22(6):1165-73. PubMed ID: 12530786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A shared response model for clustered binary data in developmental toxicity studies.
    Pang Z; Kuk AY
    Biometrics; 2005 Dec; 61(4):1076-84. PubMed ID: 16401281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On a likelihood-based goodness-of-fit test of the beta-binomial model.
    Garren ST; Smith RL; Piegorsch WW
    Biometrics; 2000 Sep; 56(3):947-50. PubMed ID: 10985242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statistical methods for the beta-binomial model in teratology.
    Yamamoto E; Yanagimoto T
    Environ Health Perspect; 1994 Jan; 102 Suppl 1(Suppl 1):25-31. PubMed ID: 8187716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-Response Modeling with Summary Data from Developmental Toxicity Studies.
    Fox JF; Hogan KA; Davis A
    Risk Anal; 2017 May; 37(5):905-917. PubMed ID: 27567129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mathematical modeling of reproductive and developmental toxic effects for quantitative risk assessment.
    Kodell RL; Howe RB; Chen JJ; Gaylor DW
    Risk Anal; 1991 Dec; 11(4):583-90. PubMed ID: 1780500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Wilson's principles--a base of modern teratology].
    Burdan F; Bełzek A; Szumiło J; Dudka J; Korobowicz A; Tokarska E; Klepacz L; Bełzek M; Klepacz R
    Pol Merkur Lekarski; 2006 Mar; 20(117):358-61. PubMed ID: 16780275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dose-response model for teratological experiments involving quantal responses.
    Rai K; Van Ryzin J
    Biometrics; 1985 Mar; 41(1):1-9. PubMed ID: 4005367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teratology testing: I. Development and status of short-term prescreens. II. Biotransformation of teratogens as studied in whole embryo culture.
    Shepard TH; Fantel AG; Mirkes PE; Greenaway JC; Faustman-Watts E; Campbell M; Juchau MR
    Prog Clin Biol Res; 1983; 135():147-64. PubMed ID: 6364154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose response in human teratology.
    Shepard TH
    Teratology; 2002 May; 65(5):199-200. PubMed ID: 11967913
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of generalized estimating equations for risk assessment in developmental toxicity.
    Ryan L
    Risk Anal; 1992 Sep; 12(3):439-47. PubMed ID: 1410710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interval estimation of binomial proportion in clinical trials with a two-stage design.
    Tsai WY; Chi Y; Chen CM
    Stat Med; 2008 Jan; 27(1):15-35. PubMed ID: 17566141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of the median lethal dose when responses within a little are correlated.
    Segreti AC; Munson AE
    Biometrics; 1981 Mar; 37(1):153-6. PubMed ID: 7195746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Problems associated with the screening of drugs for possible teratogenic activity.
    Palmer AK
    Exp Embryol Teratol; 1974; 1(0):16-33. PubMed ID: 4464051
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms.
    Gupta U; Cook JC; Tassinari MS; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):27-37. PubMed ID: 12852481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.